Scintigraphic evaluation of rhBMP-2-biocoated implants reveals no ectopic bone formation

Biomedicine and Pharmacotherapy

Volumn 65, Issue 1, 2011, Pages 63-68

  Lehmann, L J ^a   Werner, A ^b   Dinter, D J ^b   Mauermann, E ^a   Seidling, R ^a   Brade, J ^a   Laub, M ^c   Luers, S ^c   Madenci, S ^c   Jennissen, H ^c   Obertacke, U ^a   Scharf, H P ^a   Schwarz, M L ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b MEDICAL FACULTY MANNHEIM HEIDELBERG UNIVERSITY   (Germany)

^c UNIVERSITY OF DUISBURG ESSEN   (Germany)

Author keywords

Ectopic bone formation; RhBMP 2; Scintigraphy

Indexed keywords

RECOMBINANT BONE MORPHOGENETIC PROTEIN 2; SULFURIC ACID; TITANIUM;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BONE SCINTISCANNING; CONTROLLED STUDY; FEMALE; FEMUR; IMPLANT; IMPLANTATION; METAPHYSIS; MINIPIG; NONHUMAN; OSSIFICATION; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RECOMBINANT BONE MORPHOGENETIC PROTEIN 2 BIOCOATED IMPLANT;

ANIMALS; BONE MORPHOGENETIC PROTEIN 2; COATED MATERIALS, BIOCOMPATIBLE; HUMANS; IMPLANTS, EXPERIMENTAL; OSTEOGENESIS; RECOMBINANT PROTEINS; SWINE; SWINE, MINIATURE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 79951674777     PISSN: 07533322     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopha.2010.10.008     Document Type: Article

References (31)

1. Kirker-Head C.A. Recombinant bone morphogenetic proteins: novel substances for enhancing bone healing. Vet Surg 1995, 24(5):408-419.
2. Zegzula H.D., Buck D.C., Brekke J., Wozney J.M., Hollinger J.O. Bone formation with use of rhBMP-2 (recombinant human bone morphogenetic protein-2). J Bone Joint Surg Am 1997, 79(12):1778-1790.
3. Cook S.D., Baffes G.C., Wolfe M.W., Sampath T.K., Rueger D.C. Recombinant human bone morphogenetic protein-7 induces healing in a canine long-bone segmental defect model. Clin Orthop Relat Res 1994, (301):302-312.
4. Cook S.D., Baffes G.C., Wolfe M.W., Sampath T.K., Rueger D.C., Whitecloud T.S. The effect of recombinant human osteogenic protein-1 on healing of large segmental bone defects. J Bone Joint Surg Am 1994, 76(6):827-838.
5. Sumner D.R., Turner T.M., Urban R.M., Turek T., Seeherman H., Wozney J.M. Locally delivered rhBMP-2 enhances bone ingrowth and gap healing in a canine model. J Orthop Res 2004, 22(1):58-65.
6. Jennissen H.P. Accelerated and improved osteointegration of implants biocoated with bone morphogenetic protein 2 (BMP-2). Ann N Y Acad Sci 2002, 961:139-142.
7. Hartl K., Chatzinikolaidou A.S., Jennissen M., Majetschak H., Voggenreiter M.G. Biologische Beschichtung von Implantaten mit rhBMP-2. Hefte z Unfallchir 2001, 283:383-384.
8. Becker J.K.A., Schwarz F., Chatzinikolaidou M., Rothamel D., Lekovic V., Laub M.J.H. Bone apposition to titanium implants biocoated with recombinant human bone morphogenetic protein-2 (rhBMP-2). A pilot study in dogs. Clin Oral Investig 2006, 10(3):217-224. [Epub 2006 May 9].
9. Yoshida K., Bessho K., Fujimura K., Kusumoto K., Ogawa Y., Tani Y., et al. Osteoinduction capability of recombinant human bone morphogenetic protein-2 in intramuscular and subcutaneous sites: an experimental study. J Craniomaxillofac Surg 1998, 26(2):112-115.
10. Axelrad T.W., Steen B., Lowenberg D.W., Creevy W.R., Einhorn T.A. Heterotopic ossification after the use of commercially available recombinant human bone morphogenetic proteins in four patients. J Bone Joint Surg Br 2008, 90(12):1617-1622.
11. Varady P., Li J.Z., Alden T.D., Kallmes D.F., Williams M.B., Helm G.A. CT and radionuclide study of BMP-2 gene therapy-induced bone formation. Acad Radiol 2002, 9(6):632-637.
12. Ghanem N., Uhl M., Brink I., Schafer O., Kelly T., Moser E., et al. Diagnostic value of MRI in comparison to scintigraphy, PET, MS-CT and PET/CT for the detection of metastases of bone. Eur J Radiol 2005, 55(1):41-55.
13. Jennissen H.P., Chatzinikolaidou Z.T., Steppuhn M.J. Biocoating of implants with mediator molecules: surface enhancement of metals by treatment with chromosulfuric acid. Mat Wiss Werkstofftech 1999, 30:838-845.
14. Schwarz M.L., Seidling R., Mauermann E., Werner A., Steil V., Forsch E., et al. Scintigraphic evaluation of Göttingen Minipigs. Scand J Lab Anim Sci 2010, 37(1):13-16.
15. Hönig J.F. Das Göttinger Miniaturschwein (GMS) als Versuchstier in der human-medizinischen osteologischen Grundlagenforschung. Z Zahnärztl Implantol 1993, 9:244-254.
16. Schwarz M.L., Kowarsch M., Rose S., Becker K., Lenz T., Jani L. Effect of surface roughness, porosity, and a resorbable calcium phosphate coating on osseointegration of titanium in a minipig model. J Biomed Mater Res A 2009, 89(3):667-678.
17. Howell T.H., Fiorellini J., Jones A., Alder M., Nummikoski P., Lazaro M., et al. A feasibility study evaluating rhBMP-2/absorbable collagen sponge device for local alveolar ridge preservation or augmentation. Int J Periodontics Restorative Dent 1997, 17(2):124-139.
18. Matin K., Senpuku H., Hanada N., Ozawa H., Ejiri S. Bone regeneration by recombinant human bone morphogenetic protein-2 around immediate implants: a pilot study in rats. Int J Oral Maxillofac Implants 2003, 18(2):211-217.
19. Wikesjo U.M., Sorensen R.G., Kinoshita A., Wozney J.M. RhBMP-2/alphaBSM induces significant vertical alveolar ridge augmentation and dental implant osseointegration. Clin Implant Dent Relat Res 2002, 4(4):174-182.
20. Becker J., Kirsch A., Schwarz F., Chatzinikolaidou M., Rothamel D., Lekovic V., et al. Bone apposition to titanium implants biocoated with recombinant human bone morphogenetic protein-2 (rhBMP-2). A pilot study in dogs. Clin Oral Investig 2006, 10(3):217-224.
21. Lecoeur L., Ouhayoun J.P. In vitro induction of osteogenic differentiation from non-osteogenic mesenchymal cells. Biomaterials 1997, 18(14):989-993.
22. Küsswetter W.T.M. Gentechnisch induziertes Knochenwachstum. Deutsches Ärzteblatt 1999, 28:989-993.
23. Boraiah S., Paul O., Hawkes D., Wickham M., Lorich D.G. Complications of recombinant human BMP-2 for treating complex tibial plateau fractures: a preliminary report. Clin Orthop Relat Res 2009, 467(12):3257-3262. [Epub 2009 Aug 20].
24. Brower R.S., Vickroy N.M. A case of psoas ossification from the use of BMP-2 for posterolateral fusion at L4-L5. Spine 2008, 33:E653-E655.
25. Wong D.A., Kumar A., Jatana S., Ghiselli G., Wong K. Neurologic impairment from ectopic bone in the lumbar spine: a potential complication of off label PLIF/TLIF use of bone morphogenetic protein-2 (BMP-2). Spine J 2008, 8(6):1011-1018. [Epub 2007 Nov 26].
26. Wysocki R.W., Cohen M.S. Ectopic ossification of the triceps muscle after application of bone morphogenetic protein-7 to the distal humerus for recalcitrant nonunion: a case report. J Hand Surg [Am] 2007, 32(5):647-650.
27. Saito A., Suzuki Y., Ogata S., Ohtsuki C., Tanihara M. Prolonged ectopic calcification induced by BMP-2-derived synthetic peptide. J Biomed Mater Res A 2004, 70(1):115-121.
28. Shields L.B., Raque G.H., Glassman S.D., Campbell M., Vitaz T., Harpring J., et al. Adverse effects associated with high-dose recombinant human bone morphogenetic protein-2 use in anterior cervical spine fusion. Spine 2006, 31(5):542-547.
29. Tumialan L.M., Rodts G.E. Adverse swelling associated with use of rh-BMP-2 in anterior cervical discectomy and fusion. Spine J 2007, 7(4):509-510.
30. Vaidya R., Carp J., Sethi A., Bartol S., Craig J., Les C.M. Complications of anterior cervical discectomy and fusion using recombinant human bone morphogenetic protein-2. Eur Spine J 2007, 16(8):1257-1265.
31. Vaidya R., Weir R., Sethi A., Meisterling S., Hakeos W., Wybo C.D. Interbody fusion with allograft and rhBMP-2 leads to consistent fusion but early subsidence. J Bone Joint Surg Br 2007, 89(3):342-345.